| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/10/2004 | US20040109857 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 06/10/2004 | US20040109847 Treatment and prophylaxis with 4-1BB-binding agents |
| 06/10/2004 | US20040109843 Pharmaceutical composition containing decoy and use of the same |
| 06/10/2004 | US20040109835 comprising comb copolymers based on acryloyldimethyltaurine |
| 06/10/2004 | CA2854831A1 Treatment of mammalian reaction to ige interactions |
| 06/10/2004 | CA2507616A1 Highly stable pacap/vip-derived peptides |
| 06/10/2004 | CA2506948A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 06/10/2004 | CA2506683A1 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 06/09/2004 | EP1426375A2 Analgesic spiroindole derivatives |
| 06/09/2004 | EP1426060A1 Remedies for allergic diseases |
| 06/09/2004 | EP1426059A1 Remedies for pruritus |
| 06/09/2004 | EP1426055A1 Targeted protein degradation vehicles (tpdvs), nucleic acid constructs encoding them and their use |
| 06/09/2004 | EP1426050A1 Jnk inhibitors |
| 06/09/2004 | EP1426034A1 Hair growth tonic |
| 06/09/2004 | EP1426030A1 Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof |
| 06/09/2004 | EP1425580A2 Lymphatic endothelial cells materials and methods |
| 06/09/2004 | EP1425389A2 Human antibodies specific for interleukin 15 (il-15) |
| 06/09/2004 | EP1425381A2 Emu-based formulations for wound treatment related application information |
| 06/09/2004 | EP1425308A2 Polysaccharidic esters of retinoic acid |
| 06/09/2004 | EP1425284A2 Furo- and thienopyrimidine derivatives as angiogenesis inhibitors |
| 06/09/2004 | EP1425281A1 Chemical compounds |
| 06/09/2004 | EP1425280A2 Hetero-bicyclic crf antagonists |
| 06/09/2004 | EP1425258A2 Hydroxyeicosenoic acid analogs |
| 06/09/2004 | EP1425256A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions |
| 06/09/2004 | EP1425035A1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 06/09/2004 | EP1425030A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 06/09/2004 | EP1425001A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/09/2004 | EP1424998A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/09/2004 | EP1424892A2 Modulation of angiogenesis by a-beta peptides |
| 06/09/2004 | EP1212323B1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 06/09/2004 | EP1198237B1 Herbal compositions for itchy or infected skin |
| 06/09/2004 | EP1148875B1 Methods and compositions to enhance white blood cell count |
| 06/09/2004 | EP1054687A4 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 06/09/2004 | EP1036089B1 Wound healing compositions |
| 06/09/2004 | DE10320633A1 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von lebenden Zellen, die einem Reiz ausgesetzt wurden, und lebenden Zellen, die nicht diesem Reiz ausgesetzt wurden A method of identifying a possible modification of at least one biological parameter using living cells that were exposed to a stimulus, and living cells that were not exposed to this stimulus |
| 06/09/2004 | DE10320603A1 Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann A method for testing the activity of a possible active substance which inhibit the enzymatic activity of phospholipase A2 can |
| 06/09/2004 | DE10320602A1 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von jungen und alten lebenden Zellen A method for identifying a possible modification of at least one biological parameters using young and old living cells |
| 06/09/2004 | CN1503806A Pepties from the 16/6id antibody for treating SLE |
| 06/09/2004 | CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors |
| 06/09/2004 | CN1503673A antiinflammation agents |
| 06/09/2004 | CN1503672A 6-substituted pyrido-pyrimidines |
| 06/09/2004 | CN1503655A Sugar intake promoters |
| 06/09/2004 | CN1502629A Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide |
| 06/09/2004 | CN1502628A Polyglycol modification article for acidic fibroblast growth factor and its mutant |
| 06/09/2004 | CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/09/2004 | CN1502608A Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity |
| 06/09/2004 | CN1502368A Application of recombinant adenovirus in treating cerebral ischemia, traumatic restoration and tissue adhesion |
| 06/09/2004 | CN1502366A Aerhua melanophore-stimulating hormone cream for treating vitiligo |
| 06/09/2004 | CN1502365A Sesame flower extract, preparation method and use thereof |
| 06/09/2004 | CN1502363A Process for preparing traditional Chinese medicine to treat burn and scald |
| 06/09/2004 | CN1502359A Prunella spike oral liquid and preparation process thereof |
| 06/09/2004 | CN1502348A Ointment for curing burn |
| 06/09/2004 | CN1502344A Multi-function medicine for beautifying and treating scald by boiled water and fire and cold injury, and special container |
| 06/09/2004 | CN1502320A Moxibustion for treating skin superficial early and intermediate cancer and boil |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/09/2004 | CN1152877C Piperazine derivatives |
| 06/09/2004 | CN1152867C Quinazoline derivatives as medicaments |
| 06/09/2004 | CN1152864C Phenylphenanthridines with PDE-IV inhibiting activity |
| 06/09/2004 | CN1152863C Substituted pyridines as selective coclooxygenase-2-inhibitors and composition thereof |
| 06/09/2004 | CN1152703C Medicinal composition for treating skin itchings |
| 06/09/2004 | CN1152689C Activated vitamin D3 emulsion-type lotions |
| 06/09/2004 | CN1152675C IL-8 receptor antagonists |
| 06/08/2004 | US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication |
| 06/08/2004 | US6747134 Antibody immunologically reactive with serine protease EOS |
| 06/08/2004 | US6747061 N-substituted dithiocarbamates for the treatment of biological disorders |
| 06/08/2004 | US6747040 Imidazonaphthyridines |
| 06/08/2004 | US6747035 Antiinflammatory agents; antiallergens |
| 06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
| 06/08/2004 | US6747026 NK-1 receptor active amine oxide prodrugs |
| 06/08/2004 | US6747017 Endopeptidase inhibitor |
| 06/08/2004 | US6747005 Determining importin alpha activities in presence and absence of camp-response element binding protein which acetylates importin alpha to determine effect on activities, comparing effect in presence and absence of test compound |
| 06/08/2004 | US6746666 Micropigment mixture |
| 06/08/2004 | CA2307552C Substituted pyridine compounds as anti-inflammatory agents |
| 06/08/2004 | CA2233219C Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration |
| 06/03/2004 | WO2004046380A1 Psoriasis diagnostics and therapeutics |
| 06/03/2004 | WO2004046146A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 06/03/2004 | WO2004045609A2 Hydroxypyridinones for the local treatment of skin microcirculatory disorders |
| 06/03/2004 | WO2004045602A1 Drug for inhibiting production of matrix metalloprotease-9 |
| 06/03/2004 | WO2004045599A1 Therapeutic delivery of carbon monoxide |
| 06/03/2004 | WO2004045571A1 Use of polymers, which contain basic amine groups, in cosmetic, dermatological or pharmaceutical formulations |
| 06/03/2004 | WO2004045563A2 Method of treatment of myocardial infarction |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004026222A3 Compositions which are used to care for skin suffering from a hormonal imbalance and which contain one or more resveratrol oligomers, particularly $g(e)-viniferin, and/or certain derivatives thereof |
| 06/03/2004 | WO2003092595A3 Tyrosine kinase inhibitors |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | WO2003075900A3 Utilization of ubiquinones for influencing the effect of histamine |
| 06/03/2004 | WO2003063800A8 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | WO2003048153A8 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 06/03/2004 | WO2003006104A8 Lymphatic endothelial cells materials and methods |
| 06/03/2004 | WO2002070457A8 Inhibitor of monoamine uptake |
| 06/03/2004 | WO1997035010A8 Chemokine alpha 2 |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106730 Polymer complexes of glucuronoglucanes |
| 06/03/2004 | US20040106683 show selectivity to the MC1 and MC4 melanocortin receptors as agonists and/or antagonists |
| 06/03/2004 | US20040106682 Novel benzylideneamino guanidines and their uses as ligands to the melnocortin receptors |
| 06/03/2004 | US20040106679 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |